Business Analyst corner- Reiterate ‘buy’ on Piramal Enterprises; co re-strategised its business, increased distribution reach News Desk January 13, 2021 We remain positive on PIEL on superior execution across pharma segments and an increasing retail-focused lending book. Piramal Enterprises (PIEL) has built a differentiated and robust business model in the …